19
Views
149
CrossRef citations to date
0
Altmetric
Gene Expression

Promoter-Dependent Mechanism Leading to Selective Hypomethylation within the 5′ Region of Gene MAGE-A1 in Tumor Cells

, &
Pages 4781-4790 | Received 23 Dec 2003, Accepted 14 Mar 2004, Published online: 27 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Pragya Srivastava, Benjamin E Paluch, Junko Matsuzaki, Smitha R James, Golda Collamat-Lai, Pietro Taverna, Adam R Karpf & Elizabeth A Griffiths. (2015) Immunomodulatory action of the DNA methyltransferase inhibitor SGI-110 in epithelial ovarian cancer cells and xenografts . Epigenetics 10:3, pages 237-246.
Read now
Axelle Loriot, Aurélie Van Tongelen, Jordi Blanco, Simon Klaessens, Julie Cannuyer, Nicolas van Baren, Anabelle Decottignies & Charles De Smet. (2014) A novel cancer-germline transcript carrying pro-metastatic miR-105 and TET-targeting miR-767 induced by DNA hypomethylation in tumors. Epigenetics 9:8, pages 1163-1171.
Read now
Gaëlle Tilman, Nausica Arnoult, Sandrine Lenglez, Amandine Van Beneden, Axelle Loriot, Charles De Smet & Anabelle Decottignies. (2012) Cancer-linked satellite 2 DNA hypomethylation does not regulate Sat2 non-coding RNA expression and is initiated by heat shock pathway activation. Epigenetics 7:8, pages 903-913.
Read now
Morten Frier Gjerstorff, Jorge Burns & Henrik Jorn Ditzel. (2010) Cancer–germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment. Expert Opinion on Biological Therapy 10:7, pages 1061-1075.
Read now
Hugues JM Nicolay, Luca Sigalotti, Ester Fonsatti, Alessia Covre, Giulia Parisi, Elisabetta Fratta, Sandra Coral & Michele Maio. (2009) Epigenetically regulated tumor-associated antigens in melanoma. Expert Review of Dermatology 4:2, pages 145-154.
Read now
Jae‐Bum Bae & Young‐Joon Kim. (2008) Cancer and epigenetics. Animal Cells and Systems 12:3, pages 117-125.
Read now
Mukesh Verma, Padma Maruvada & Sudhir Srivastava. (2004) Epigenetics and Cancer. Critical Reviews in Clinical Laboratory Sciences 41:5-6, pages 585-607.
Read now

Articles from other publishers (141)

Franco Andrés Pascucci, Micaela Carolina Escalada, Melisa Suberbordes, Candela Vidal, María Fátima Ladelfa & Martín Monte. (2023) MAGE-I proteins and cancer-pathways: A bidirectional relationship. Biochimie 208, pages 31-37.
Crossref
Bing Cheng, Qiang Yu & Wenyu Wang. (2023) Intimate communications within the tumor microenvironment: stromal factors function as an orchestra. Journal of Biomedical Science 30:1.
Crossref
Özgür TEKİN, Yiğit UYANIKGİL & Dilek TAŞKIRAN. (2022) Effect of glucagon-like peptide-1 on differentiation of adipose derived mesenchymal stem cells into cardiomyocytesGlukagon benzeri peptit-1'in yağ doku kaynaklı mezenkimal kök hücrelerinin kardiyomiyositlere dönüşmesi üzerindeki etkisi. Ege Tıp Dergisi 61:4, pages 507-517.
Crossref
Runjhun Mathur, Niraj Kumar Jha, Gaurav Saini, Saurabh Kumar Jha, Sheo Prasad Shukla, Zita Filipejová, Kavindra Kumar Kesari, Danish Iqbal, Parma Nand, Vijay Jagdish Upadhye, Abhimanyu Kumar Jha, Shubhadeep Roychoudhury & Petr Slama. (2022) Epigenetic factors in breast cancer therapy. Frontiers in Genetics 13.
Crossref
Zeenat Farooq, Ambreen Shah, Mohammad Tauseef, Riyaz Ahmad Rather & Mumtaz Anwar. 2022. Epigenetics to Optogenetics - A New Paradigm in the Study of Biology. Epigenetics to Optogenetics - A New Paradigm in the Study of Biology.
Toshikazu Ushijima, Yumi Furuichi, Hideyuki Takeshima & Naoko Hattori. 2022. Epigenetic Epidemiology. Epigenetic Epidemiology 343 361 .
Jonathan D. Licht & Richard L. Bennett. (2021) Leveraging epigenetics to enhance the efficacy of immunotherapy. Clinical Epigenetics 13:1.
Crossref
Vivek Kumar Sharma, Thakur Gurjeet Singh, Shareen Singh, Nikhil Garg & Sonia Dhiman. (2021) Apoptotic Pathways and Alzheimer’s Disease: Probing Therapeutic Potential. Neurochemical Research 46:12, pages 3103-3122.
Crossref
Chaeun Oh, Hwa-Ryeon Kim, Sumin Oh, Je Yeong Ko, Yesol Kim, Keunsoo Kang, Young Yang, Jongmin Kim, Jong Hoon Park, Jae-Seok Roe & Kyung Hyun Yoo. (2021) Epigenetic Upregulation of MAGE-A Isoforms Promotes Breast Cancer Cell Aggressiveness. Cancers 13:13, pages 3176.
Crossref
Franco Andrés Pascucci, María Fátima Ladelfa, María Fernanda Toledo, Micaela Escalada, Melisa Suberbordes & Martín Monte. (2021) MageC2 protein is upregulated by oncogenic activation of MAPK pathway and causes impairment of the p53 transactivation function. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1868:3, pages 118918.
Crossref
Ashley Colemon, Taylor M. Harris & Saumya Ramanathan. (2020) DNA hypomethylation drives changes in MAGE-A gene expression resulting in alteration of proliferative status of cells. Genes and Environment 42:1.
Crossref
Rebecca R. Florke Gee, Helen Chen, Anna K. Lee, Christina A. Daly, Benjamin A. Wilander, Klementina Fon Tacer & Patrick Ryan Potts. (2020) Emerging roles of the MAGE protein family in stress response pathways. Journal of Biological Chemistry 295:47, pages 16121-16155.
Crossref
Kelly Olino, Tristen Park & Nita Ahuja. (2020) Exposing Hidden Targets: Combining epigenetic and immunotherapy to overcome cancer resistance. Seminars in Cancer Biology 65, pages 114-122.
Crossref
Victoria M. Kim, Xingyi Pan, Kevin C. Soares, Nilofer S. Azad, Nita Ahuja, Christopher J. Gamper, Alex B. Blair, Stephen Muth, Ding Ding, Brian H. Ladle & Lei Zheng. (2020) Neoantigen-based EpiGVAX vaccine initiates antitumor immunity in colorectal cancer. JCI Insight 5:9.
Crossref
Wenzhen Xie, Haibo Zhou, Qian Han, Tong Sun, Chuang Nie, Jia Hong, Rongrong Wei, Anastasiia Leonteva, Xu Han, Jing Wang, Xinyu Du, Lin Zhu, Yashuang Zhao, Wenjing Tian & Yingwei Xue. (2020) Relationship between DLEC1 and PBX3 promoter methylation and the risk and prognosis of gastric cancer in peripheral blood leukocytes. Journal of Cancer Research and Clinical Oncology 146:5, pages 1115-1124.
Crossref
Satoshi Yamashita, Sohachi Nanjo, Emil Rehnberg, Naoko Iida, Hideyuki Takeshima, Takayuki Ando, Takao Maekita, Toshiro Sugiyama & Toshikazu Ushijima. (2019) Distinct DNA methylation targets by aging and chronic inflammation: a pilot study using gastric mucosa infected with Helicobacter pylori. Clinical Epigenetics 11:1.
Crossref
Cathal McCrory, Sinead McLoughlin & Aisling M. O’Halloran. (2019) Socio-Economic Position Under the Microscope: Getting ‘Under the Skin’ and into the Cells. Current Epidemiology Reports 6:4, pages 403-411.
Crossref
Tomoko Hirakawa, Kaei Nasu, Yoko Aoyagi, Kanetoshi Takebayashi, Ruofei Zhu & Hisashi Narahara. (2019) ATM expression is attenuated by promoter hypermethylation in human ovarian endometriotic stromal cells. Molecular Human Reproduction 25:6, pages 295-304.
Crossref
Christiana A. Demetriou, Karin van Veldhoven, Caroline Relton, Silvia Stringhini, Kyriacos Kyriacou & Paolo Vineis. 2019. Handbook of Nutrition, Diet, and Epigenetics. Handbook of Nutrition, Diet, and Epigenetics 1177 1192 .
Yishui Lian, Lingjiao Meng, Pingan Ding & Meixiang Sang. (2018) Epigenetic regulation of MAGE family in human cancer progression-DNA methylation, histone modification, and non-coding RNAs. Clinical Epigenetics 10:1.
Crossref
Olga Gordeeva. (2018) Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy. Seminars in Cancer Biology 53, pages 75-89.
Crossref
Gerd Pfeifer. (2018) Defining Driver DNA Methylation Changes in Human Cancer. International Journal of Molecular Sciences 19:4, pages 1166.
Crossref
Jovana Klajic & Vessela Kristensen. 2018. Epigenetic Mechanisms in Cancer. Epigenetic Mechanisms in Cancer 141 168 .
Aurélie Van Tongelen, Axelle Loriot & Charles De Smet. (2017) Oncogenic roles of DNA hypomethylation through the activation of cancer-germline genes. Cancer Letters 396, pages 130-137.
Crossref
Julieta E. Laiseca, María F. Ladelfa, Javier Cotignola, Leticia Y. Peche, Franco A. Pascucci, Bryan A. Castaño, Mario D. Galigniana, Claudio Schneider & Martin Monte. (2017) Functional interaction between co-expressed MAGE-A proteins. PLOS ONE 12:5, pages e0178370.
Crossref
N R Hilal, D V Novikov, V V Novikov & A V Karaulov. (2017) Cancer-testis genes in colon cancer. Terapevticheskii arkhiv 89:5, pages 113-117.
Crossref
Hideyuki Takeshima & Toshikazu Ushijima. 2017. DNA and Histone Methylation as Cancer Targets. DNA and Histone Methylation as Cancer Targets 607 622 .
Christiana A. Demetriou, Karin van Veldhoven, Caroline Relton, Silvia Stringhini, Kyriacos Kyriacou & Paolo Vineis. 2017. Handbook of Nutrition, Diet, and Epigenetics. Handbook of Nutrition, Diet, and Epigenetics 1 16 .
Aaraby Nielsen & Morten Gjerstorff. (2016) Ectopic Expression of Testis Germ Cell Proteins in Cancer and Its Potential Role in Genomic Instability. International Journal of Molecular Sciences 17:6, pages 890.
Crossref
M. Yu. Shkurnikov, E. N. Knyazev, D. Wicklein, U. Schumacher, T. R. Samatov & A. G. Tonevitskii. (2016) Role of L1CAM in the Regulation of the Canonical Wnt Pathway and Class I MAGE Genes. Bulletin of Experimental Biology and Medicine 160:6, pages 807-810.
Crossref
Zdenko Herceg. 2016. Hypoxia. Hypoxia 3 15 .
Soichiro Funaki, Toshinobu Nakamura, Tsunetoshi Nakatani, Hiroki Umehara, Hiroyuki Nakashima, Meinoshin Okumura, Keisuke Oboki, Kenji Matsumoto, Hirohisa Saito & Toru Nakano. (2015) Global DNA hypomethylation coupled to cellular transformation and metastatic ability. FEBS Letters 589:24PartB, pages 4053-4060.
Crossref
Julie Cannuyer, Aurélie Van Tongelen, Axelle Loriot & Charles De Smet. (2015) A gene expression signature identifying transient DNMT1 depletion as a causal factor of cancer-germline gene activation in melanoma. Clinical Epigenetics 7:1.
Crossref
Benjamin Chalopin, Laetitia Florenceau, Delphine Fradin, Nathalie Labarrière & Agnès Moreau-Aubry. (2015) A lineage-specific methylation pattern controls the transcription of the polycistronic mRNA coding MELOE melanoma antigens. Melanoma Research 25:4, pages 279-283.
Crossref
Phanni bhushann Meka, Sarika Jarjapu, Santhoshi Rani Nanchari, Sandeep Kumar Vishwakarma, Prajitha Mohandas Edathara, Manjula Gorre, Anuradha Cingeetham, Sugunakar Vuree, Sandhya Annamaneni, Nageswara Rao Dunna, Srinivasulu Mukta, B Triveni & Vishnupriya Satti. (2015) LCN2 Promoter Methylation Status as Novel Predictive Marker for Microvessel Density and Aggressive Tumor Phenotype in Breast Cancer Patients. Asian Pacific Journal of Cancer Prevention 16:12, pages 4965-4969.
Crossref
David Z. Kochan & Olga Kovalchuk. (2015) Circadian disruption and breast cancer: An epigenetic link?. Oncotarget 6:19, pages 16866-16882.
Crossref
Intza Garin, Giovanna Mantovani, Urko Aguirre, Anne Barlier, Bettina Brix, Francesca M Elli, Kathleen Freson, Virginie Grybek, Benedetta Izzi, Agnès Linglart, Guiomar Perez de Nanclares, Caroline Silve, Susanne Thiele & Ralf Werner. (2014) European guidance for the molecular diagnosis of pseudohypoparathyroidism not caused by point genetic variants at GNAS: an EQA study. European Journal of Human Genetics 23:4, pages 438-444.
Crossref
Christiana A. Demetriou, Karin van Veldhoven, Caroline Relton, Silvia Stringhini, Kyriacos Kyriacou & Paolo Vineis. (2015) Biological embedding of early-life exposures and disease risk in humans: a role for DNA methylation. European Journal of Clinical Investigation 45:3, pages 303-332.
Crossref
Hideyuki Takeshima, Tohru Niwa, Takamasa Takahashi, Mika Wakabayashi, Satoshi Yamashita, Takayuki Ando, Yuki Inagawa, Hirokazu Taniguchi, Hitoshi Katai, Toshiro Sugiyama, Tohru Kiyono & Toshikazu Ushijima. (2015) Frequent involvement of chromatin remodeler alterations in gastric field cancerization. Cancer Letters 357:1, pages 328-338.
Crossref
Bowen Yan, Xuehui Li, Alta Johnson, Yurong Yang, Wei Jian & Yi Qiu. 2015. Epigenetic Gene Expression and Regulation. Epigenetic Gene Expression and Regulation 397 423 .
Rajnee Kanwal, Karishma Gupta & Sanjay Gupta. 2015. Cancer Epigenetics. Cancer Epigenetics 3 25 .
Heidi Schwarzenbach, Corinna Eichelser, Bettina Steinbach, Josefine Tadewaldt, Klaus Pantel, Victor Lobanenkov & Dmitri Loukinov. (2014) Differential regulation of MAGE-A1 promoter activity by BORIS and Sp1, both interacting with the TATA binding protein. BMC Cancer 14:1.
Crossref
Yunqiang Liu, Meiling Wang, Siyuan Jiang, Yongjie Lu, Dachang Tao, Yuan Yang, Yongxin Ma & Sizhong Zhang. (2014) Demethylation of CpG islands in the 5' upstream regions mediates the expression of the human testis-specific gene MAGEB16 and its mouse homolog Mageb16. BMB Reports 47:2, pages 86-91.
Crossref
Fang-Wei Xie, Yong-Hai Peng, Xi Chen, Xiong Chen, Jie Li, Zong-Yang Yu, Wen-Wu Wang & Xue-Nong Ouyang. (2014) Regulation and expression of aberrant methylation on irinotecan metabolic genes CES2, UGT1A1 and GUSB in the in-vitro cultured colorectal cancer cells. Biomedicine & Pharmacotherapy 68:1, pages 31-37.
Crossref
Yoshitomo Chihara, Yae Kanai, Hiroyuki Fujimoto, Kokichi Sugano, Kiyotaka Kawashima, Gangning Liang, Peter A Jones, Kiyohide Fujimoto, Hiroki Kuniyasu & Yoshihiko Hirao. (2013) Diagnostic markers of urothelial cancer based on DNA methylation analysis. BMC Cancer 13:1.
Crossref
Robert Kim, Prakash Kulkarni & Sridhar Hannenhalli. (2013) Derepression of Cancer/Testis Antigens in cancer is associated with distinct patterns of DNA Hypomethylation. BMC Cancer 13:1.
Crossref
Letícia F. Terra, Priscila C. Teixeira, Rosangela A.M. Wailemann, André Zelanis, Giuseppe Palmisano, Edecio Cunha-Neto, Jorge Kalil, Martin R. Larsen, Leticia Labriola & Mari C. Sogayar. (2013) Proteins differentially expressed in human beta-cells-enriched pancreatic islet cultures and human insulinomas. Molecular and Cellular Endocrinology 381:1-2, pages 16-25.
Crossref
Shun Zhang, Gang Kuang, Guodong Zhao, Xue Wu, Cheng Zhang, Rongrong Lei, Tao Xia, Jianbin Chen, Zhenglun Wang, Rulin Ma, Bei Li, Lu Yang & Aiguo Wang. (2013) Involvement of the mitochondrial p53 pathway in PBDE-47-induced SH-SY5Y cells apoptosis and its underlying activation mechanism. Food and Chemical Toxicology 62, pages 699-706.
Crossref
Lukasz A. Kacprzyk, Mark Laible, Tatjana Andrasiuk, Jan C. Brase, Stefan T. Börno, Maria Fälth, Ruprecht Kuner, Hans Lehrach, Michal R. Schweiger & Holger Sültmann. (2013) ERG Induces Epigenetic Activation of Tudor Domain-Containing Protein 1 (TDRD1) in ERG Rearrangement-Positive Prostate Cancer. PLoS ONE 8:3, pages e59976.
Crossref
Julie Cannuyer, Axelle Loriot, Grégory K. Parvizi & Charles De Smet. (2013) Epigenetic Hierarchy within the MAGEA1 Cancer-Germline Gene: Promoter DNA Methylation Dictates Local Histone Modifications. PLoS ONE 8:3, pages e58743.
Crossref
Paul Wilkerson & J Reis-Filho. 2013. Early Breast Cancer. Early Breast Cancer 286 304 .
Charles De Smet & Axelle Loriot. 2013. Epigenetic Alterations in Oncogenesis. Epigenetic Alterations in Oncogenesis 149 166 .
María Fátima Ladelfa, Leticia Yamila Peche, María Fernanda Toledo, Julieta Eva Laiseca, Claudio Schneider & Martín Monte. (2012) Tumor-specific MAGE proteins as regulators of p53 function. Cancer Letters 325:1, pages 11-17.
Crossref
G. S. Gupta. (2012) LDH-C4: a target with therapeutic potential for cancer and contraception. Molecular and Cellular Biochemistry 371:1-2, pages 115-127.
Crossref
JUTTA RIES, ABBAS AGAIMY, ELEFTERIOS VAIRAKTARIS, YEEUN KWON, FRIEDRICH W. NEUKAM, LEI H. STRASSBURG & EMEKA NKENKE. (2012) Evaluation of MAGE-A expression and grade of dysplasia for predicting malignant progression of oral leukoplakia. International Journal of Oncology 41:3, pages 1085-1093.
Crossref
Mizuho Kikuyama, Hideyuki Takeshima, Takayuki Kinoshita, Eriko Okochi-Takada, Mika Wakabayashi, Sadako Akashi-Tanaka, Toshihisa Ogawa, Yasuyuki Seto & Toshikazu Ushijima. (2012) Development of a novel approach, the epigenome-based outlier approach, to identify tumor-suppressor genes silenced by aberrant DNA methylation. Cancer Letters 322:2, pages 204-212.
Crossref
Manuel Rosa-Garrido, Laura Ceballos, Pilar Alonso-Lecue, Cristina Abraira, M. Dolores Delgado & Alberto Gandarillas. (2012) A Cell Cycle Role for the Epigenetic Factor CTCF-L/BORIS. PLoS ONE 7:6, pages e39371.
Crossref
Huan Qiao & James M. May. (2012) Interaction of the Transcription Start Site Core Region and Transcription Factor YY1 Determine Ascorbate Transporter SVCT2 Exon 1a Promoter Activity. PLoS ONE 7:4, pages e35746.
Crossref
Paul A. Ginno, Paul L. Lott, Holly C. Christensen, Ian Korf & Frédéric Chédin. (2012) R-Loop Formation Is a Distinctive Characteristic of Unmethylated Human CpG Island Promoters. Molecular Cell 45:6, pages 814-825.
Crossref
Axelle Loriot, Grégory K. Parvizi, Sven Reister & Charles De Smet. (2012) Silencing of cancer-germline genes in human preimplantation embryos: Evidence for active de novo DNA methylation in stem cells. Biochemical and Biophysical Research Communications 417:1, pages 187-191.
Crossref
Toshikazu Ushijima & Hideyuki Takeshima. 2012. Epigenetic Epidemiology. Epigenetic Epidemiology 269 288 .
Nicolas van Baren, Jean-François Baurain, Francis Brasseur & Pierre G. Coulie. 2012. Targeted Therapeutics in Melanoma. Targeted Therapeutics in Melanoma 187 205 .
N. Mollaoglu, P. Metzler, J. Zenk, E. Nkenke, F. W. Neukam & J. Ries. (2011) Prediction of recurrence using exfoliative cytology and melanoma-associated antigen-A mRNA analysis following wide excision of oral squamous cell carcinoma: short report. Cytopathology 22:6, pages 387-391.
Crossref
Huan QiaoJames M. May. (2011) CpG methylation at the USF-binding site mediates cell-specific transcription of human ascorbate transporter SVCT2 exon 1a. Biochemical Journal 440:1, pages 73-84.
Crossref
Pauliina Damdimopoulou, Stefan Weis, Ivan Nalvarte & Joëlle Rüegg. 2011. Hormone-Disruptive Chemical Contaminants in Food. Hormone-Disruptive Chemical Contaminants in Food 44 69 .
Hideyuki Takeshima, Satoshi Yamashita, Taichi Shimazu & Toshikazu Ushijima. (2011) Effects of genome architecture and epigenetic factors on susceptibility of promoter CpG islands to aberrant DNA methylation induction. Genomics 98:3, pages 182-188.
Crossref
Kaei Nasu, Yukie Kawano, Yoshiyuki Tsukamoto, Masayuki Takano, Noriyuki Takai, Haili Li, Yuichi Furukawa, Wakana Abe, Masatsugu Moriyama & Hisashi Narahara. (2011) Aberrant DNA methylation status of endometriosis: Epigenetics as the pathogenesis, biomarker and therapeutic target. Journal of Obstetrics and Gynaecology Research 37:7, pages 683-695.
Crossref
Mahadev Rao, Nachimuthu Chinnasamy, Julie A. Hong, Yuwei Zhang, Mary Zhang, Sichuan Xi, Fang Liu, Victor E. Marquez, Richard A. Morgan & David S. Schrump. (2011) Inhibition of Histone Lysine Methylation Enhances Cancer–Testis Antigen Expression in Lung Cancer Cells: Implications for Adoptive Immunotherapy of Cancer. Cancer Research 71:12, pages 4192-4204.
Crossref
Cyril Cuffel, Jean-Paul Rivals, Yannick Zaugg, Suzanne Salvi, Walter Seelentag, Daniel E. Speiser, Danielle Liénard, Philippe Monnier, Pedro Romero, Luc Bron & Donata Rimoldi. (2011) Pattern and clinical significance of cancer-testis gene expression in head and neck squamous cell carcinoma. International Journal of Cancer 128:11, pages 2625-2634.
Crossref
Yousri M. Hussein, Amal F. Gharib, Rasha L. Etewa, Amal S. El-Shal, Mohamed Esmat Abdel-Ghany & Wael H. Elsawy. (2011) The melanoma-associated antigen-A3, -A4 genes: relation to the risk and clinicopathological parameters in breast cancer patients. Molecular and Cellular Biochemistry 351:1-2, pages 261-268.
Crossref
Elisabetta Fratta, Sandra Coral, Alessia Covre, Giulia Parisi, Francesca Colizzi, Riccardo Danielli, Hugues Jean Marie Nicolay, Luca Sigalotti & Michele Maio. (2011) The biology of cancer testis antigens: Putative function, regulation and therapeutic potential. Molecular Oncology 5:2, pages 164-182.
Crossref
Filipe Ivan Daniel, Karen Cherubini, Liliane Soares Yurgel, Maria Antonia Zancanaro de Figueiredo & Fernanda Gonçalves Salum. (2011) The role of epigenetic transcription repression and DNA methyltransferases in cancer. Cancer 117:4, pages 677-687.
Crossref
Keun Su Son, Han-Sung Kang, Sun Jung Kim, So-Youn Jung, Sun Young Min, See Youn Lee, Seok Won Kim, Youngmee Kwon, Keun Seok Lee, Kyung Hwan Shin & Jungsil Ro. (2010) Hypomethylation of the interleukin-10 gene in breast cancer tissues. The Breast 19:6, pages 484-488.
Crossref
María Berdasco & Manel Esteller. (2010) Aberrant Epigenetic Landscape in Cancer: How Cellular Identity Goes Awry. Developmental Cell 19:5, pages 698-711.
Crossref
Enrique I. Miranda. (2010) MAGE, biological functions and potential clinical applications. Leukemia Research 34:9, pages 1121-1122.
Crossref
Carolina Schinke, Yongkai Mo, Yiting Yu, Kathy Amiri, Jeff Sosman, John Greally & Amit Verma. (2010) Aberrant DNA methylation in malignant melanoma. Melanoma Research 20:4, pages 253-265.
Crossref
D. Monk. (2010) Deciphering the cancer imprintome. Briefings in Functional Genomics 9:4, pages 329-339.
Crossref
Elizabeth M. Wilson. (2010) Androgen receptor molecular biology and potential targets in prostate cancer. Therapeutic Advances in Urology 2:3, pages 105-117.
Crossref
Jovana Jovanovic, Jo Anders Rønneberg, Jörg Tost & Vessela Kristensen. (2010) The epigenetics of breast cancer. Molecular Oncology 4:3, pages 242-254.
Crossref
Sebastian Dango, Xiao Tao Wang, Monika Gold, Beatrix Cucuruz, Christoph A. Klein, Bernward Passlick & Wulf Sienel. (2010) Expression of melanoma-antigen-A (MAGE-A) in disseminated tumor cells in regional lymph nodes of patients with operable non-small cell lung cancer. Lung Cancer 67:3, pages 290-295.
Crossref
Yao-Tseng ChenAmy ChadburnPeishan Lee, Melinda Hsu, Erika Ritter, April ChiuSacha Gnjatic, Michael Pfreundschuh, Daniel M. KnowlesLloyd J. Old. (2010) Expression of cancer testis antigen CT45 in classical Hodgkin lymphoma and other B-cell lymphomas. Proceedings of the National Academy of Sciences 107:7, pages 3093-3098.
Crossref
Tohru Niwa, Tetsuya Tsukamoto, Takeshi Toyoda, Akiko Mori, Harunari Tanaka, Takao Maekita, Masao Ichinose, Masae Tatematsu & Toshikazu Ushijima. (2010) Inflammatory Processes Triggered by Helicobacter pylori Infection Cause Aberrant DNA Methylation in Gastric Epithelial Cells . Cancer Research 70:4, pages 1430-1440.
Crossref
Toshikazu Ushijima & Kiyoshi Asada. (2010) Aberrant DNA methylation in contrast with mutations. Cancer Science 101:2, pages 300-305.
Crossref
Krishna Vanaja Donkena, Charles Y. F. Young & Donald J. Tindall. (2010) Oxidative Stress and DNA Methylation in Prostate Cancer. Obstetrics and Gynecology International 2010, pages 1-14.
Crossref
Tohru Niwa & Toshikazu Ushijima. 2010. Epigenetics and Cancer, Part B. Epigenetics and Cancer, Part B 41 56 .
Tomomitsu Tahara, Tomoyuki Shibata, Masakatsu Nakamura, Hiromi Yamashita, Daisuke Yoshioka, Masaaki Okubo, Naoko Maruyama, Toshiaki Kamano, Yoshio Kamiya, Hiroshi Fujita, Mitsuo Nagasaka, Masami Iwata, Kazuya Takahama, Makoto Watanabe, Ichiro Hirata & Tomiyasu Arisawa. (2009) Chronic Aspirin Use Suppresses CDH1 Methylation in Human Gastric Mucosa. Digestive Diseases and Sciences 55:1, pages 54-59.
Crossref
Zdenko Herceg & Paolo Boffetta. 2010. Environmental Factors, Genes, and the Development of Human Cancers. Environmental Factors, Genes, and the Development of Human Cancers 153 196 .
Hideyuki Takeshima, Satoshi Yamashita, Taichi Shimazu, Tohru Niwa & Toshikazu Ushijima. (2009) The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islands. Genome Research 19:11, pages 1974-1982.
Crossref
Sophie RousseauxSaadi Khochbin. (2009) New hypotheses for large-scale epigenome alterations in somatic cancer cells: a role for male germ-cell-specific regulators. Epigenomics 1:1, pages 153-161.
Crossref
S. Yamashita, K. Hosoya, K. Gyobu, H. Takeshima & T. Ushijima. (2009) Development of a Novel Output Value for Quantitative Assessment in Methylated DNA Immunoprecipitation-CpG Island Microarray Analysis. DNA Research 16:5, pages 275-286.
Crossref
Aik Choon Tan, Antonio Jimeno, Steven H. Lin, Jenna Wheelhouse, Fonda Chan, Anna Solomon, N.V. Rajeshkumar, Belen Rubio-Viqueira & Manuel Hidalgo. (2009) Characterizing DNA methylation patterns in pancreatic cancer genome. Molecular Oncology 3:5-6, pages 425-438.
Crossref
Hyeong Ryul Kim, Tae Hun Kim, Jin-Haeng Chung, Ho Il Yoon, Choon Taek Lee, Chang Hyun Kang, Sanghoon Jheon, Sook Whan Sung, Joo Hyun Kim & Changho Jeon. (2009) The detection of peripheral lung cancer by MAGE A1–6 RT-nested PCR in bronchial washing specimens. Lung Cancer 65:2, pages 166-169.
Crossref
Morten Gjerstorff, Jorge S. Burns, Ole Nielsen, Moustapha Kassem & Henrik Ditzel. (2009) Epigenetic Modulation of Cancer-Germline Antigen Gene Expression in Tumorigenic Human Mesenchymal Stem Cells. The American Journal of Pathology 175:1, pages 314-323.
Crossref
Tomomitsu Tahara, Tomoyuki Shibata, Hiromi Yamashita, Masakatsu Nakamura, Daisuke Yoshioka, Masaaki Okubo, Ichiro Hirata & Tomiyasu Arisawa. (2009) Chronic nonsteroidal anti-inflammatory drug (NSAID) use suppresses multiple CpG islands hyper methylation (CIHM) of tumor suppressor genes in the human gastric mucosa. Cancer Science 100:7, pages 1192-1197.
Crossref
Petra A. Link, Omkaram Gangisetty, Smitha R. James, Anna Woloszynska-Read, Makoto Tachibana, Yoichi Shinkai & Adam R. Karpf. (2009) Distinct Roles for Histone Methyltransferases G9a and GLP in Cancer Germ-Line Antigen Gene Regulation in Human Cancer Cells and Murine Embryonic Stem Cells. Molecular Cancer Research 7:6, pages 851-862.
Crossref
Yaping Li, Amr H. Sawalha & Qianjin Lu. (2009) Aberrant DNA methylation in skin diseases. Journal of Dermatological Science 54:3, pages 143-149.
Crossref
Tomomitsu Tahara, Tomoyuki Shibata, Masakatsu Nakamura, Hiromi Yamashita, Daisuke Yoshioka, Masaaki Okubo, Naoko Maruyama, Toshiaki Kamano, Yoshio Kamiya, Hiroshi Fujita, Yoshihito Nakagawa, Mitsuo Nagasaka, Masami Iwata, Kazuya Takahama, Makoto Watanabe, Hiroshi Nakano, Ichiro Hirata & Tomiyasu Arisawa. (2009) Promoter methylation of protease-activated receptor (PAR2) is associated with severe clinical phenotypes of ulcerative colitis (UC). Clinical and Experimental Medicine 9:2, pages 125-130.
Crossref
G Tilman, A Loriot, A Van Beneden, N Arnoult, J A Londoño-Vallejo, C De Smet & A Decottignies. (2009) Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells. Oncogene 28:14, pages 1682-1693.
Crossref
Elena Grau, Silvestre Oltra, Francisco Martínez, Carmen Orellana, Adela Cañete, Jose María Fernández, Miguel Hernández-Martí & Victoria Castel. (2008) MAGE-A1 expression is associated with good prognosis in neuroblastoma tumors. Journal of Cancer Research and Clinical Oncology 135:4, pages 523-531.
Crossref
Takeshi Nakajima, Satoshi Yamashita, Takao Maekita, Tohru Niwa, Kazuyuki Nakazawa & Toshikazu Ushijima. (2009) The presence of a methylation fingerprint of Helicobacter pylori infection in human gastric mucosae . International Journal of Cancer 124:4, pages 905-910.
Crossref
Yann Godet, Agnès Moreau-Aubry, Yannik Guilloux, Virginie Vignard, Amir Khammari, Brigitte Dreno, Francine Jotereau & Nathalie Labarriere. (2008) MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency. Journal of Experimental Medicine 205:11, pages 2673-2682.
Crossref
L.A. Hogarth, C.P.F. Redfern, J.M. Teodoridis, A.G. Hall, H. Anderson, M.C. Case & S.A. Coulthard. (2008) The effect of thiopurine drugs on DNA methylation in relation to TPMT expression. Biochemical Pharmacology 76:8, pages 1024-1035.
Crossref
Peter Molloy. 2008. Cancer Epigenetics. Cancer Epigenetics 7 37 .
Sophie Rousseaux, Nicolas Reynoird, Jonathan Gaucher & Saadi Khochbin. (2008) L’intrusion des régulateurs de l’épigénome mâle dans les cellules somatiques cancéreuses. médecine/sciences 24:8-9, pages 735-741.
Crossref
Olga Kholmanskikh, Axelle Loriot, Francis Brasseur, Etienne De Plaen & Charles De Smet. (2008) Expression of BORIS in melanoma: Lack of association with MAGE-A1 activation . International Journal of Cancer 122:4, pages 777-784.
Crossref
Tibor A. RauchXueyan ZhongXiwei Wu, Melody WangKemp H. Kernstine, Zunde WangArthur D. RiggsGerd P. Pfeifer. (2008) High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Proceedings of the National Academy of Sciences 105:1, pages 252-257.
Crossref
Mariko Watanabe, Yuji Ogawa, Kinji Itoh, Tukasa Koiwa, Marshall E Kadin, Toshiki Watanabe, Isao Okayasu, Masaaki Higashihara & Ryouichi Horie. (2008) Hypomethylation of CD30 CpG islands with aberrant JunB expression drives CD30 induction in Hodgkin lymphoma and anaplastic large cell lymphoma. Laboratory Investigation 88:1, pages 48-57.
Crossref
Kim Appleton, Helen J. Mackay, Ian Judson, Jane A. Plumb, Carol McCormick, Gordon Strathdee, Chooi Lee, Sophie Barrett, Sarah Reade, Dalal Jadayel, Adrian Tang, Katharine Bellenger, Lynsay Mackay, Albert Setanoians, Andreas Schätzlein, Chris Twelves, Stanley B. Kaye & Robert Brown. (2007) Phase I and Pharmacodynamic Trial of the DNA Methyltransferase Inhibitor Decitabine and Carboplatin in Solid Tumors. Journal of Clinical Oncology 25:29, pages 4603-4609.
Crossref
Tino Schenk, Sven Stengel, Stefanie Goellner, Daniel Steinbach & Hans Peter Saluz. (2007) Hypomethylation of PRAME is responsible for its aberrant overexpression in human malignancies . Genes, Chromosomes and Cancer 46:9, pages 796-804.
Crossref
Frank Wischnewski, Olaf Friese, Klaus Pantel & Heidi Schwarzenbach. (2007) Methyl-CpG Binding Domain Proteins and Their Involvement in the Regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 Gene Promoters. Molecular Cancer Research 5:7, pages 749-759.
Crossref
Wulf Sienel, Ingo Mecklenburg, Sebastian Dango, Peter Ehrhardt, Andreas Kirschbaum, Bernward Passlick & Klaus Pantel. (2007) Detection of MAGE-A Transcripts in Bone Marrow Is an Independent Prognostic Factor in Operable Non–Small-Cell Lung Cancer. Clinical Cancer Research 13:13, pages 3840-3847.
Crossref
Anshu Agrawal, Richard F Murphy & Devendra K Agrawal. (2007) DNA methylation in breast and colorectal cancers. Modern Pathology 20:7, pages 711-721.
Crossref
Kazuki Moriguchi, Satoshi Yamashita, Yoshimi Tsujino, Masae Tatematsu & Toshikazu Ushijima. (2007) Larger numbers of silenced genes in cancer cell lines with increased de novo methylation of scattered CpG sites. Cancer Letters 249:2, pages 178-187.
Crossref
Michael Weber, Ines Hellmann, Michael B Stadler, Liliana Ramos, Svante Pääbo, Michael Rebhan & Dirk Schübeler. (2007) Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nature Genetics 39:4, pages 457-466.
Crossref
Toshikazu Ushijima. (2007) Epigenetic Field for Cancerization. BMB Reports 40:2, pages 142-150.
Crossref
S R James, P A Link & A R Karpf. (2006) Epigenetic regulation of X-linked cancer/germline antigen genes by DNMT1 and DNMT3b. Oncogene 25:52, pages 6975-6985.
Crossref
Mami Mihara, Yukinari Yoshida, Tetsuya Tsukamoto, Ken-ichi Inada, Yukihiro Nakanishi, Yukiko Yagi, Kohzoh Imai, Takashi Sugimura, Masae Tatematsu & Toshikazu Ushijima. (2006) Methylation of Multiple Genes in Gastric Glands with Intestinal Metaplasia. The American Journal of Pathology 169:5, pages 1643-1651.
Crossref
Thomas B. Tomasi, William J. Magner & A. Nazmul H. Khan. (2006) Epigenetic regulation of immune escape genes in cancer. Cancer Immunology, Immunotherapy 55:10, pages 1159-1184.
Crossref
Danielle M. MaatoukLori D. KellamMellissa R. W. MannHong LeiEn LiMarisa S. BartolomeiJames L. Resnick. (2006) DNA methylation is a primary mechanism for silencing postmigratory primordial germ cell genes in both germ cell and somatic cell lineages. Development 133:17, pages 3411-3418.
Crossref
S M Pulukuri & J S Rao. (2006) CpG island promoter methylation and silencing of 14-3-3σ gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2. Oncogene 25:33, pages 4559-4572.
Crossref
Norihiro Sato & Michael Goggins. (2006) The role of epigenetic alterations in pancreatic cancer. Journal of Hepato-Biliary-Pancreatic Surgery 13:4, pages 286-295.
Crossref
Yu. V. Vakhitova, S. V. Sadovnikov, R. S. Yamidanov & S. B. Seredenin. (2006) Cytosine demethylation in the tyrosine hydroxylase gene promoter in hypothalamus cells of rat brain under the action of 2-aminoadamantane compound Ladasten. Russian Journal of Genetics 42:7, pages 795-801.
Crossref
Junichi Furuta, Yoshimasa Nobeyama, Yoshihiro Umebayashi, Fujio Otsuka, Kanako Kikuchi & Toshikazu Ushijima. (2006) Silencing of Peroxiredoxin 2 and Aberrant Methylation of 33 CpG Islands in Putative Promoter Regions in Human Malignant Melanomas . Cancer Research 66:12, pages 6080-6086.
Crossref
M F Gjerstorff, L E Johansen, O Nielsen, K Kock & H J Ditzel. (2006) Restriction of GAGE protein expression to subpopulations of cancer cells is independent of genotype and may limit the use of GAGE proteins as targets for cancer immunotherapy. British Journal of Cancer 94:12, pages 1864-1873.
Crossref
Frank Wischnewski, Klaus Pantel & Heidi Schwarzenbach. (2006) Promoter Demethylation and Histone Acetylation Mediate Gene Expression of MAGE-A1, -A2, -A3 , and -A12 in Human Cancer Cells . Molecular Cancer Research 4:5, pages 339-349.
Crossref
Axelle Loriot, Etienne De Plaen, Thierry Boon & Charles De Smet. (2006) Transient Down-regulation of DNMT1 Methyltransferase Leads to Activation and Stable Hypomethylation of MAGE-A1 in Melanoma Cells. Journal of Biological Chemistry 281:15, pages 10118-10126.
Crossref
Takao Maekita, Kazuyuki Nakazawa, Mami Mihara, Takeshi Nakajima, Kimihiko Yanaoka, Mikitaka Iguchi, Kenji Arii, Atsushi Kaneda, Tetsuya Tsukamoto, Masae Tatematsu, Gen Tamura, Daizo Saito, Takashi Sugimura, Masao Ichinose & Toshikazu Ushijima. (2006) High Levels of Aberrant DNA Methylation in Helicobacter pylori –Infected Gastric Mucosae and its Possible Association with Gastric Cancer Risk . Clinical Cancer Research 12:3, pages 989-995.
Crossref
Kyung-Hee Kim. (2006) Promoter hypomethylation and reactivation of MAGE-A1 and MAGE-A3 genes in colorectal cancer cell lines and cancer tissues . World Journal of Gastroenterology 12:35, pages 5651.
Crossref
W. A. Schulz, C. Steinhoff & A. R. Florl. 2006. DNA Methylation: Development, Genetic Disease and Cancer. DNA Methylation: Development, Genetic Disease and Cancer 211 250 .
N. Watanabe, E. Okochi-Takada, Y. Yagi, J. -I. Furuta & T. Ushijima. 2006. DNA Methylation: Development, Genetic Disease and Cancer. DNA Methylation: Development, Genetic Disease and Cancer 199 210 .
Frank Lyko & Robert Brown. (2005) DNA Methyltransferase Inhibitors and the Development of Epigenetic Cancer Therapies. JNCI: Journal of the National Cancer Institute 97:20, pages 1498-1506.
Crossref
Sergei Vatolin, Ziedulla Abdullaev, Svetlana D. Pack, Patrick T. Flanagan, Mary Custer, Dmitri I. Loukinov, Elena Pugacheva, Julie A. Hong, Herbert MorseIIIIII, David S. Schrump, John I. Risinger, J. Carl Barrett & Victor V. Lobanenkov. (2005) Conditional Expression of the CTCF-Paralogous Transcriptional Factor BORIS in Normal Cells Results in Demethylation and Derepression of MAGE-A1 and Reactivation of Other Cancer-Testis Genes. Cancer Research 65:17, pages 7751-7762.
Crossref
Julie A. Hong, Yang Kang, Ziedulla Abdullaev, Patrick T. Flanagan, Svetlana D. Pack, Maria R. Fischette, Mina T. Adnani, Dmitri I. Loukinov, Sergei Vatolin, John I. Risinger, Mary Custer, G. Aaron Chen, Ming Zhao, Dao M. Nguyen, J. Carl Barrett, Victor V. Lobanenkov & David S. Schrump. (2005) Reciprocal Binding of CTCF and BORIS to the NY-ESO-1 Promoter Coincides with Derepression of this Cancer-Testis Gene in Lung Cancer Cells. Cancer Research 65:17, pages 7763-7774.
Crossref
Kazuaki Miyamoto, Takashi Fukutomi, Sadako Akashi-Tanaka, Tadashi Hasegawa, Toshimasa Asahara, Takashi Sugimura & Toshikazu Ushijima. (2005) Identification of 20 genes aberrantly methylated in human breast cancers. International Journal of Cancer 116:3, pages 407-414.
Crossref
Joana Paredes, André Albergaria, João T. Oliveira, Carmen Jerónimo, Fernanda Milanezi & Fernando C. Schmitt. (2005) P-Cadherin Overexpression Is an Indicator of Clinical Outcome in Invasive Breast Carcinomas and Is Associated with CDH3 Promoter Hypomethylation . Clinical Cancer Research 11:16, pages 5869-5877.
Crossref
N. P. Kisseljova & F. L. Kisseljov. (2005) DNA Demethylation and Carcinogenesis. Biochemistry (Moscow) 70:7, pages 743-752.
Crossref
Toshikazu Ushijima & Eriko Okochi-Takada. (2005) Aberrant methylations in cancer cells: Where do they come from?. Cancer Science 96:4, pages 206-211.
Crossref
Toshikazu Ushijima. (2005) Detection and interpretation of altered methylation patterns in cancer cells. Nature Reviews Cancer 5:3, pages 223-231.
Crossref
Shan Zha & William B. Isaacs. (2005) A Nonclassic CCAAT Enhancer Element Binding Protein Binding Site Contributes to α-Methylacyl-CoA Racemase Expression in Prostate Cancer. Molecular Cancer Research 3:2, pages 110-118.
Crossref
Masanobu Abe, Miki Ohira, Atsushi Kaneda, Yukiko Yagi, Seiichiro Yamamoto, Yoshihiro Kitano, Tsuyoshi Takato, Akira Nakagawara & Toshikazu Ushijima. (2005) CpG Island Methylator Phenotype Is a Strong Determinant of Poor Prognosis in Neuroblastomas. Cancer Research 65:3, pages 828-834.
Crossref
Toshikazu Ushijima, Naoko Watanabe, Kimiko Shimizu, Kazuaki Miyamoto, Takashi Sugimura & Atsushi Kaneda. (2005) Decreased Fidelity in Replicating CpG Methylation Patterns in Cancer Cells. Cancer Research 65:1, pages 11-17.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.